March 22, 2018 / 12:43 PM / a month ago

BRIEF-U.S. FDA Grants Fee Waiver For Tamsulosin Drs New Drug Application

March 22 (Reuters) - Veru Inc:

* FDA GRANTS FEE WAIVER FOR TAMSULOSIN DRS NEW DRUG APPLICATION

* VERU - U.S. FDA GRANTED APPLICATION FOR SMALL BUSINESS WAIVER OF DRUG APPLICATION FEE OF ABOUT$2.4 MILLION FOR NDA FOR TAMSULOSIN DELAYED RELEASE SACHET Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below